Adding Specialist Palliative Care to Transplantation Pilot Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Specialist palliative care has been shown to be beneficial for patients experiencing serious illness, but has not been studied for patients being evaluated for liver transplantation. The investigators hope in the future to design a multi-center trial of a specialist palliative care intervention to measure the effects of specialist palliative care for patients undergoing liver transplant evaluation. This project represents a pilot to gather needed information to design such a future study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Palliative Care for Non-Malignant Diseases (COMPASS Trial)

NCT03022630

Liver Diseases Liver Cirrhosis NASH (Non-Alcoholic Steatohepatitis)

TERMINATED NA

LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease

NCT04953143

Cirrhosis, Liver

COMPLETED NA

An Integrative Model for Palliative Care in End-Stage Liver Disease

NCT05238779

End Stage Liver DIsease

COMPLETED

LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease

NCT05998330

Liver Disease Chronic End Stage Liver DIsease Cirrhosis +2 more

RECRUITING NA

Palliative Care for Patients With Liver Cirrhosis

NCT05431946

End of Life Care Liver Cirrhosis Nurse-Patient Relations +1 more

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Liver DIsease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Specialist Palliative Care

All patients will be assigned to receive the intervention, consisting of two outpatient palliative care visits at Vanderbilt University Medical Center (VUMC).

Group Type EXPERIMENTAL

Palliative Care Consultation

Intervention Type BEHAVIORAL

In person or telehealth clinic visit with palliative care physician or nurse practitioner

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Palliative Care Consultation

In person or telehealth clinic visit with palliative care physician or nurse practitioner

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (age 18 years or greater) undergoing evaluation for liver transplantation at Vanderbilt University Medical Center

Exclusion Criteria

1. Patient does not speak English fluently
2. Patient lacks a telephone
3. Patient is a prisoner
4. Patient is deaf
5. Patient currently receives specialist palliative care
6. Patient is not a resident of Tennessee

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No